Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 267-051-0
CAS number: 67774-74-7
No clinical signs were observed during the experiment.
A single intravenous dose of test substance was given to 5 male and 5
female rats. Samples of urine and feces were taken at pre-dose, 0.5, 4,
8, 24, 72, and 96 hrs post-dose. Whole body autoradiography was done for
1 animal of each sex at 0.5, 4, 8, 24, and 96 hrs after dosing. No
clinical signs were observed during the study. The test substance was
rapidly eliminated from the majority of tissues, though some remained in
fatty tissues. Metabolism of the test substance was rapid, and it was
eliminated mostly through the urine.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
Welcome to the ECHA website. This site is not fully supported in Internet Explorer 7 (and earlier versions). Please upgrade your Internet Explorer to a newer version.
Do not show this message again